ID: ALA3612190

Max Phase: Preclinical

Molecular Formula: C9H13N

Molecular Weight: 135.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C1=CC2CC=CCN2CC1

Standard InChI:  InChI=1S/C9H13N/c1-3-7-10-8-4-2-6-9(10)5-1/h1-3,6,9H,4-5,7-8H2

Standard InChI Key:  CJUQLGSHASMMRU-UHFFFAOYSA-N

Associated Targets(Human)

X-box-binding protein 1 1001 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 135.21Molecular Weight (Monoisotopic): 135.1048AlogP: 1.58#Rotatable Bonds: 0
Polar Surface Area: 3.24Molecular Species: BASEHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.72CX LogP: 1.54CX LogD: 0.20
Aromatic Rings: 0Heavy Atoms: 10QED Weighted: 0.46Np Likeness Score: 1.19

References

1. Zhang ZH, Zhang HJ, Deng AJ, Wang B, Li ZH, Liu Y, Wu LQ, Wang WJ, Qin HL..  (2015)  Synthesis and Structure-Activity Relationships of Quaternary Coptisine Derivatives as Potential Anti-ulcerative Colitis Agents.,  58  (18): [PMID:26321079] [10.1021/acs.jmedchem.5b00964]

Source